Novavax’s protein-based vaccine approval fails to boost stock as demand for shots and boosters remains low
admin U.S. health regulators authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option…
Read Morenew products
FDA approves Novavax’s COVID-19 vaccine for those 18 and older
U.S. health regulators have authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new…
Read MoreNetflix looks to renegotiate programming deals to allow ads to be shown
Netflix Inc. is seeking to amend its programming deals with major entertainment studios to allow…
Read MorePS5 restock: Best Buy to have Play Station 5’s this week, but there’s a catch
Best Buy BBY, +1.44% is set to get a major restock of the highly sought-after…
Read MoreEV startup Lightyear boasts a production-ready solar car
Lately, there are more new electric cars than seems reasonable. Is there consumer demand for…
Read MoreBlack patients were rarely included in clinical trials — until COVID-19 vaccines
Stephanie Walker, a Black retired nurse who was diagnosed with metastatic breast cancer in 2015,…
Read More